retatrutide phase 2 obesity trial for Obesity: Weight-Loss Data Retatrutide hits 28% weight loss

[DOI] [PMC free article] [PubMed] [Google Scholar] 147.Parker JA, McCullough KA, Field BC, Minnion JS, Martin NM, Ghatei MA, Bloom SR

Between managing your hormone levels and symptoms like hot flashes, night sweats, sleep disturbances and weight gain, it can feel as though just as you get one thing under control, another symptom or complication arises

For menopausal women specifically, this dual action on appetite and metabolic control addresses two major obstacles to sustainable weight management

doi: 10.1016/S2213-8587(15)00436-2 59 FrandsenCSDejgaardTFHolstJJAndersenHUThorsteinssonBMadsbadS

Regulatory dialogue appears to be coalescing around an add-on development pathway, with FDA feedback informing dose, duration, endpoints, and selection of GLP-1experienced populations

A strategy for maintaining weight loss through diet and exercise will be important after stopping Semaglutide